Display Settings:

Format

Send to:

Choose Destination
    Am J Trop Med Hyg. 2009 May;80(5):737-8.

    Malaria drug shortages in Kenya: a major failure to provide access to effective treatment.

    Source

    Malaria Public Health and Epidemiology Group, Kenya Medical Research Institute/Wellcome Trust Programme Nairobi, Kenya. bkangwana@nairobi.kemri-wellcome.org

    Abstract

    A key bench mark of successful therapeutic policy implementation, and thus effectiveness, is that the recommended drugs are available at the point of care. Two years after artemether-lumefathrine (AL) was introduced for the management of uncomplicated malaria in Kenya, we carried out a cross-sectional survey to investigate AL availability in government facilities in seven malaria-endemic districts. One of four of the surveyed facilities had none of the four AL weight-specific treatment packs in stock; three of four facilities were out of stock of at least one weight-specific AL pack, leading health workers to prescribe a range of inappropriate alternatives. The shortage was in large part caused by a delayed procurement process. National ministries of health and the international community must address the current shortcomings facing antimalarial drug supply to the public sector.

    PMID:
    19407116
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2679204
    Free PMC Article

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk